High-Resolution Melting Analysis for Screening of Turkish Germline Mutations in BRCA1 and BRCA2

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history

  2008cited by this paper
• Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis

  2008cited by this paper
• High-resolution DNA melting analysis for simple and efficient molecular diagnostics.

  2007cited by this paper
• High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.

  2006cited by this paper
• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  2003cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• BRCA1 and BRCA2 mutations in Russian familial breast cancer

  2002cited by this paper
• Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

  2002cited by this paper
• Common hereditary cancers and implications for primary care.

  2001cited by this paper
• The Tyr978X BRCA1 Mutation in Non-Ashkenazi Jews: Occurrence in High-Risk Families, General Population and Unselected Ovarian Cancer Patients

  2001cited by this paper
• BRCA1 mutation analysis in breast/ovarian cancer families from Greece

  2000cited by this paper
• BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients

  2000cited by this paper
• Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.

  2000cited by this paper
• Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.

  2000cited by this paper
• A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.

  2000cited by this paper
• A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC

  1999cited by this paper
• Frequency of BRCA1 mutation 5382insC in German breast cancer patients.

  1999cited by this paper
• A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers

  1999cited by this paper
• Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population

  1998cited by this paper
• The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.

  1998cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• Update on breast cancer susceptibility genes.

  1998cited by this paper
• The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

  1997cited by this paper
• A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.

  1997cited by this paper
• Population genetics of BRCA1 and BRCA2.

  1997cited by this paper
• Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families

  1996cited by this paper
• A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.

  1996cited by this paper
• Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

  1996cited by this paper
• Fortnightly Review: Familial breast cancer

  1994cited by this paper

• Variation in BMPR1B, TGFRB1 and BMPR2 and Control of Dizygotic Twinning

  2011cites this paper